Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/bf01816434.

Title:
Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis | Rheumatology International
Description:
Objective. To investigate the effects of desferrioxamine (DFO) infusion on chronic disease anemia (CDA) of rheumatoid arthritis (RA) by evaluating interleukin-6 (IL-6) and erythropoietin (EPO) production.Patients and methods. Five patients with RA and CDA (group I) were treated with DFO, 500 mg daily, through a continuous 10-h subcutaneous infusion 5 days a week for 4 weeks. One month after withdrawal, DFO was resumed in all five group I patients (group II) with an increase to 1 g daily following the previous treatment schedule. Clinical and laboratory parameters were evaluated weekly during the two study periods. Serum EPO was measured by radioimmunoassay. IL-6 was detected by the enzyme-linked immunoabsorbent assay method.Results. No significant variations in hematological parameters, IL-6 or EPO levels were observed in group I patients. After 1 week of DFO 1 g daily, reticulocyte counts and EPO improved significantly. Hemoglobin and hematocrit rose significantly after 3 weeks of 1 g daily DFO therapy. Four weeks after DFO withdrawal, EPO, reticulocyte counts, hemoglobin and hematocrit returned to baseline levels. A significant improvement in the clinical parameters of disease activity was observed, particularly in group II patients.Conclusion. DFO improves CDA in RA patients. The beneficial effects on erythropoiesis seem to be related to improved EPO responsiveness to the anemia.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {๐Ÿ“š}

  • Health & Fitness
  • Social Networks
  • Science

Content Management System {๐Ÿ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {๐Ÿ“ˆ}

What is the average monthly size of link.springer.com audience?

๐ŸŒ  Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {๐Ÿ’ธ}

We donโ€™t know how the website earns money.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {๐Ÿ”}

arthritis, rheumatoid, google, scholar, article, pubmed, erythropoietin, desferrioxamine, disease, anemia, effects, dfo, chronic, epo, access, iron, anaemia, rheumatol, privacy, cookies, content, therapy, salvarani, lasagni, patients, group, daily, treatment, clinical, publish, search, macchioni, portioli, interleukin, italy, analysis, data, information, log, journal, research, rheumatology, baricchi, boiardi, brunati, cda, weeks, month, laboratory, parameters,

Topics {โœ’๏ธ}

month download article/chapter ospedale niguarda ca'granda potential anti-inflammatory activity hypoxia-induced erythropoietin production azienda ospedaliera arcispedale chronic disease anemia full article pdf privacy choices/manage cookies recombinant human erythropoietin hypoxia signal transduction impaired erythropoietin responsiveness blunted erythropoietin response ocular toxicity induced check access instant access iron deficiency anemia daily dfo therapy european economic area scope submit manuscript repository corticotropin injection van eijk hg medsger ta jr conditions privacy policy chronic disease hematocrit rose significantly nuova reggio emilia accepting optional cookies june 1996 volumeย 16 epo improved significantly disease activity improved epo responsiveness inferiority trial related subjects desferrioxamine therapy rheumatoid arthritis previous treatment schedule journal finder publish article salvarani article log usage analysis laboratory analysis arthritis rheum 31 dfo improves cda article cite evaluating interleukin-6 oral chelator 1 systemic disease reggio emilia privacy policy personal data

Schema {๐Ÿ—บ๏ธ}

WebPage:
      mainEntity:
         headline:Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis
         description: Objective. To investigate the effects of desferrioxamine (DFO) infusion on chronic disease anemia (CDA) of rheumatoid arthritis (RA) by evaluating interleukin-6 (IL-6) and erythropoietin (EPO) production.Patients and methods. Five patients with RA and CDA (group I) were treated with DFO, 500 mg daily, through a continuous 10-h subcutaneous infusion 5 days a week for 4 weeks. One month after withdrawal, DFO was resumed in all five group I patients (group II) with an increase to 1 g daily following the previous treatment schedule. Clinical and laboratory parameters were evaluated weekly during the two study periods. Serum EPO was measured by radioimmunoassay. IL-6 was detected by the enzyme-linked immunoabsorbent assay method.Results. No significant variations in hematological parameters, IL-6 or EPO levels were observed in group I patients. After 1 week of DFO 1 g daily, reticulocyte counts and EPO improved significantly. Hemoglobin and hematocrit rose significantly after 3 weeks of 1 g daily DFO therapy. Four weeks after DFO withdrawal, EPO, reticulocyte counts, hemoglobin and hematocrit returned to baseline levels. A significant improvement in the clinical parameters of disease activity was observed, particularly in group II patients.Conclusion. DFO improves CDA in RA patients. The beneficial effects on erythropoiesis seem to be related to improved EPO responsiveness to the anemia.
         datePublished:
         dateModified:
         pageStart:45
         pageEnd:48
         sameAs:https://doi.org/10.1007/BF01816434
         keywords:
            Desferrioxamine therapy
            Chronic disease anemia
            Rheumatoid arthritis
            Erythropoietin
            Interleukin-6
            Rheumatology
         image:
         isPartOf:
            name:Rheumatology International
            issn:
               1437-160X
               0172-8172
            volumeNumber:16
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:C. Salvarani
               affiliation:
                     name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
                     address:
                        name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R. Baricchi
               affiliation:
                     name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria
                     address:
                        name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria, Nuova Reggio Emilia, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:D. Lasagni
               affiliation:
                     name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria
                     address:
                        name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria, Nuova Reggio Emilia, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:L. Boiardi
               affiliation:
                     name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
                     address:
                        name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R. Piccinini
               affiliation:
                     name:USL di Reggio Emilia
                     address:
                        name:Laboratorio Tossicologico Unificato, USL di Reggio Emilia, Scandiano, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:C. Brunati
               affiliation:
                     name:Ospedale Niguarda Ca'Granda
                     address:
                        name:Divisione di Nefrologia e Dialisi, Ospedale Niguarda Ca'Granda, Milan, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:P. Macchioni
               affiliation:
                     name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
                     address:
                        name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:I. Portioli
               affiliation:
                     name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
                     address:
                        name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis
      description: Objective. To investigate the effects of desferrioxamine (DFO) infusion on chronic disease anemia (CDA) of rheumatoid arthritis (RA) by evaluating interleukin-6 (IL-6) and erythropoietin (EPO) production.Patients and methods. Five patients with RA and CDA (group I) were treated with DFO, 500 mg daily, through a continuous 10-h subcutaneous infusion 5 days a week for 4 weeks. One month after withdrawal, DFO was resumed in all five group I patients (group II) with an increase to 1 g daily following the previous treatment schedule. Clinical and laboratory parameters were evaluated weekly during the two study periods. Serum EPO was measured by radioimmunoassay. IL-6 was detected by the enzyme-linked immunoabsorbent assay method.Results. No significant variations in hematological parameters, IL-6 or EPO levels were observed in group I patients. After 1 week of DFO 1 g daily, reticulocyte counts and EPO improved significantly. Hemoglobin and hematocrit rose significantly after 3 weeks of 1 g daily DFO therapy. Four weeks after DFO withdrawal, EPO, reticulocyte counts, hemoglobin and hematocrit returned to baseline levels. A significant improvement in the clinical parameters of disease activity was observed, particularly in group II patients.Conclusion. DFO improves CDA in RA patients. The beneficial effects on erythropoiesis seem to be related to improved EPO responsiveness to the anemia.
      datePublished:
      dateModified:
      pageStart:45
      pageEnd:48
      sameAs:https://doi.org/10.1007/BF01816434
      keywords:
         Desferrioxamine therapy
         Chronic disease anemia
         Rheumatoid arthritis
         Erythropoietin
         Interleukin-6
         Rheumatology
      image:
      isPartOf:
         name:Rheumatology International
         issn:
            1437-160X
            0172-8172
         volumeNumber:16
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:C. Salvarani
            affiliation:
                  name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
                  address:
                     name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. Baricchi
            affiliation:
                  name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria
                  address:
                     name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria, Nuova Reggio Emilia, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:D. Lasagni
            affiliation:
                  name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria
                  address:
                     name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria, Nuova Reggio Emilia, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:L. Boiardi
            affiliation:
                  name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
                  address:
                     name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. Piccinini
            affiliation:
                  name:USL di Reggio Emilia
                  address:
                     name:Laboratorio Tossicologico Unificato, USL di Reggio Emilia, Scandiano, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:C. Brunati
            affiliation:
                  name:Ospedale Niguarda Ca'Granda
                  address:
                     name:Divisione di Nefrologia e Dialisi, Ospedale Niguarda Ca'Granda, Milan, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:P. Macchioni
            affiliation:
                  name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
                  address:
                     name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:I. Portioli
            affiliation:
                  name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
                  address:
                     name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Rheumatology International
      issn:
         1437-160X
         0172-8172
      volumeNumber:16
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
      address:
         name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
         type:PostalAddress
      name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria
      address:
         name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria, Nuova Reggio Emilia, Italy
         type:PostalAddress
      name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria
      address:
         name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria, Nuova Reggio Emilia, Italy
         type:PostalAddress
      name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
      address:
         name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
         type:PostalAddress
      name:USL di Reggio Emilia
      address:
         name:Laboratorio Tossicologico Unificato, USL di Reggio Emilia, Scandiano, Italy
         type:PostalAddress
      name:Ospedale Niguarda Ca'Granda
      address:
         name:Divisione di Nefrologia e Dialisi, Ospedale Niguarda Ca'Granda, Milan, Italy
         type:PostalAddress
      name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
      address:
         name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
         type:PostalAddress
      name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
      address:
         name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:C. Salvarani
      affiliation:
            name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
            address:
               name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
               type:PostalAddress
            type:Organization
      name:R. Baricchi
      affiliation:
            name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria
            address:
               name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria, Nuova Reggio Emilia, Italy
               type:PostalAddress
            type:Organization
      name:D. Lasagni
      affiliation:
            name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria
            address:
               name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria, Nuova Reggio Emilia, Italy
               type:PostalAddress
            type:Organization
      name:L. Boiardi
      affiliation:
            name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
            address:
               name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
               type:PostalAddress
            type:Organization
      name:R. Piccinini
      affiliation:
            name:USL di Reggio Emilia
            address:
               name:Laboratorio Tossicologico Unificato, USL di Reggio Emilia, Scandiano, Italy
               type:PostalAddress
            type:Organization
      name:C. Brunati
      affiliation:
            name:Ospedale Niguarda Ca'Granda
            address:
               name:Divisione di Nefrologia e Dialisi, Ospedale Niguarda Ca'Granda, Milan, Italy
               type:PostalAddress
            type:Organization
      name:P. Macchioni
      affiliation:
            name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
            address:
               name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
               type:PostalAddress
            type:Organization
      name:I. Portioli
      affiliation:
            name:Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova
            address:
               name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
               type:PostalAddress
            type:Organization
PostalAddress:
      name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
      name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria, Nuova Reggio Emilia, Italy
      name:Centro Trasfusionale Azienda Ospedaliera Arcispedale S. Maria, Nuova Reggio Emilia, Italy
      name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
      name:Laboratorio Tossicologico Unificato, USL di Reggio Emilia, Scandiano, Italy
      name:Divisione di Nefrologia e Dialisi, Ospedale Niguarda Ca'Granda, Milan, Italy
      name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
      name:2^ Divisione di Medicina, Unita' Reumatologica, Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia, Italy
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {๐Ÿ”—}(66)

Analytics and Tracking {๐Ÿ“Š}

  • Google Tag Manager

Libraries {๐Ÿ“š}

  • Clipboard.js
  • Prism.js

CDN Services {๐Ÿ“ฆ}

  • Crossref

3.57s.